Sherpa Venture Capital
Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Sherpa Venture Capital Information
Geographic Data
Address: No. 8 Beichen East Road
City: Beijing
State: beijing municipality
Zip: 010 100000
Country: CN
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfolio sources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2021 | Fuse Biotherapeutics | Seed | 9.5M |
| 4/2021 | EdiGene | Series B | 61.6M |
| 7/2021 | MAXVAX | Series A | - |
| 6/2022 | Yuanyin Bio | Series A | 0 |
| 3/2022 | UniXell | Seed Round | 0 |
| 1/2021 | Visen Pharmaceuticals | Series B | 0 |
| 12/2021 | MindRank AI | Series A | 19M |
| 5/2019 | New Horizon Health | Series C | 0 |
| 6/2022 | Raykol | Series A | 14.8M |
| 9/2022 | Neukio Biotherapeutics | Series A | 50M |
| 5/2022 | Ketai Bio | Series A | 14.9M |
| 11/2021 | Wuxi Biortus Biosciences | Series B | 31.3M |
| 11/2021 | Sepax Technologies | Series D | 0 |
| 12/2021 | Starna Therapeutics | Angel Round | 10M |
| 6/2022 | Changjin Biotechnology | Series A | 22M |
| 3/2021 | EpimAb Biotherapeutics | Series C | 0 |
| 3/2019 | Leto Laboratories | Series A | 3M |
| 11/2021 | Singleron Biotechnologies | Series B | 0 |
| 9/2021 | Alamar Biosciences | Series B | 80M |
| 8/2020 | Zion Pharma | Series A | 20M |
| 12/2019 | KeChow Pharma | Series C | 45M |
| 3/2022 | Yuesai Biotechnology | Seed Round | 0 |
| 7/2021 | Bota Biosciences | Series B | 100M |
| 7/2021 | Zion Pharma | Series B | 40M |
| 12/2019 | Nanovision Technology | Series B | 22.9M |
| 7/2021 | Hongyun Biotech | Series B | 15.4M |
| 5/2021 | XISOFT | Series A | 15.7M |
| 12/2022 | Huihe Healthcare | Series C | - |
| 10/2016 | Wag | Series B | 15M |
| 6/2019 | Singleron Biotechnologies | Seed Round | 14.6M |
| 6/2019 | EpimAb Biotherapeutics | Series B | 74M |
| 1/2023 | BlissBio | Series B | 14.8M |
| 4/2022 | Shenji Bio | Series A | 47.1M |
| 5/2022 | Starna Therapeutics | Series A | 0 |
| 5/2021 | Alebund Pharmaceuticals | Series B | 0 |
| 1/2019 | Immunochina | Series C | 20.6M |
| 9/2020 | Bota Biosciences | Series A | 15M |
| 7/2021 | Neukio Biotherapeutics | Angel Round | 40M |
| 11/2021 | BAKX Therapeutics | Series A | 25M |
| 9/2022 | Insight Lifetech | Series D | - |
| 8/2021 | CashBackMobileApp | Pre Seed Round | 475k |
| 9/2021 | Vision X | Series B | - |
| 9/2019 | GKHT Medical Technology | Series C | 154.5M |
| 12/2019 | Hui-Gene Therapeutics | Series A | 14.2M |
| 7/2021 | Jyss Bio | Series B | - |
| 7/2021 | PAQ Therapeutics | Series A | 0 |
| 3/2021 | Jianhai Technology | Series B | 23M |
| 7/2019 | Jianhai Technology | Series A | 14.6M |
| 2/2020 | Hongyun Biotech | Series A | 7.2M |
| 7/2019 | Joinhealth Technology | Series A | 14.6M |
| 5/2022 | Hui-Gene Therapeutics | Series C | - |
| 5/2021 | Appia Bio | Series A | 52M |
| 12/2014 | Mattermark | Series A | 0 |
| 5/2021 | MindRank AI | Seed Round | 7M |
| 6/2021 | HiFiBiO | Series D | 0 |
| 12/2021 | Pilot Biotechnology | Series C | - |
| 7/2022 | ClinChoice昆翎 | Series E | 0 |
| 9/2021 | Alebund Pharmaceuticals | Series B | 0 |
| 4/2021 | Brattea | Series B | 20M |
| 6/2018 | Hongyun Biotech | Angel Round | 3.1M |
| 1/2019 | Yosemite Clinic | Series B | 14.9M |
| 9/2020 | Jianhai Technology | Series A | 8.8M |
| 7/2022 | ClinChoice昆翎 | Series E | 0 |
| 6/2022 | Yuanyin Bio | Series A | 0 |
| 6/2022 | Raykol | Series A | 0 |
| 5/2022 | Starna Therapeutics | Series A | 0 |
| 5/2022 | Hui-Gene Therapeutics | Series C | - |
| 4/2022 | Shenji Bio | Series A | 0 |
| 3/2022 | UniXell | Seed Round | 0 |
| 3/2022 | Yuesai Biotechnology | Seed Round | 0 |
| 12/2021 | Pilot Biotechnology | Series C | - |
| 12/2021 | MindRank AI | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
